| Detected | Trial | Change |
|---|---|---|
| 2026-08-11 | NCT07466017 A Study of CS060380 Tablets in Patients With MASH and Obesity |
Enrollment closed, study ongoing |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT07282353 | A Study of CS0159 in Patients With PBC With Inadequate Response or Intolerance to UDCA | Primary Biliary Cholangitis | Recruiting |
| Phase 2 | |||
| NCT07198386 | Trial of CS060380 Tablets for Non-alcoholic Steatohepatitis (NASH) | NASH | Recruiting |
| NCT05896124 | CS0159 in Chinese Patients With PBC (Primary Biliary Cholangitis) | Primary Biliary Cholangitis (PBC) | Active, Not Recruiting |
| NCT05896137 | CS0159 in Chinese Patients With PSC (Primary Sclerosing Cholangitis) | Primary Sclerosing Cholangitis | Active, Not Recruiting |
| NCT07466017 | A Study of CS060380 Tablets in Patients With MASH and Obesity | Metabolic Dysfunction-associated Steatohepatitis (MASH) | Active, Not Recruiting |
| Phase 1 | |||
| NCT06485245 | Study to Evaluate Safety, Tolerability and Pharmacokinetics of CS060304 in Healthy and… | MASH | Active, Not Recruiting |